Publication: First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
Loading...
Program
relationships.isAuthorOf
Author
GÜMÜŞ, MAHMUT
Turk, H.
Bilir, C.
Sendur, M.
Karabulut, B.
Artac, M.
Cicin, I.
Geredeli, C.
Alacacioglu, A.
Kefeli, U.
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source
Keywords
Keywords
Citation
Isikdogan A., Turk H., Bilir C., Sendur M., Karabulut B., Artac M., Cicin I., Geredeli C., Alacacioglu A., Kefeli U., et al., -First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis-, ANNALS OF ONCOLOGY, cilt.33, 2022